Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Male gender and family history predict alopecia areata recurrence.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

PRP combined with Ayurvedic medicine may effectively treat hair loss.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Mesotherapy with natural extracts and vitamins can improve hair loss and promote regrowth in most women.

The document concludes that accurate diagnosis and understanding the type of hair disorder are crucial for treating hair loss in children.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

SMAs improve patient satisfaction and may be cost-effective for female hair loss.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Treating hair loss in both men and women is effective and improves quality of life.

PRP shows promise for short-term hair growth, especially in young men.

Omega-6 and LDL cholesterol increase the risk of hair loss.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Platelet-rich plasma treatment can effectively improve hair loss, especially in younger patients under 40 without other medical conditions.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Different patterns on the scalp help diagnose types of hair loss without needing a biopsy.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.